nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—UGT2B7—Estrogen metabolism—COMT—conduct disorder	0.0765	0.0765	CbGpPWpGaD
Silodosin—ADRA1D—Monoamine GPCRs—DRD4—conduct disorder	0.046	0.046	CbGpPWpGaD
Silodosin—ADRA1D—Amine ligand-binding receptors—DRD4—conduct disorder	0.0386	0.0386	CbGpPWpGaD
Silodosin—ADRA1B—Monoamine GPCRs—DRD4—conduct disorder	0.0382	0.0382	CbGpPWpGaD
Silodosin—ADRA1A—Monoamine GPCRs—DRD4—conduct disorder	0.0339	0.0339	CbGpPWpGaD
Silodosin—ADRA1B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0321	0.0321	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.031	0.031	CbGpPWpGaD
Silodosin—ADRA1D—Monoamine GPCRs—HTR2A—conduct disorder	0.03	0.03	CbGpPWpGaD
Silodosin—ADRA1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0285	0.0285	CbGpPWpGaD
Silodosin—ADRA1D—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0252	0.0252	CbGpPWpGaD
Silodosin—ADRA1B—Monoamine GPCRs—HTR2A—conduct disorder	0.0249	0.0249	CbGpPWpGaD
Silodosin—ABCB4—PPARA activates gene expression—EP300—conduct disorder	0.0223	0.0223	CbGpPWpGaD
Silodosin—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.0221	0.0221	CbGpPWpGaD
Silodosin—ABCB4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.0219	0.0219	CbGpPWpGaD
Silodosin—UGT2B7—Phase II conjugation—COMT—conduct disorder	0.0215	0.0215	CbGpPWpGaD
Silodosin—ADRA1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0209	0.0209	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Other—DRD4—conduct disorder	0.0204	0.0204	CbGpPWpGaD
Silodosin—UGT2B7—NRF2 pathway—SLC6A4—conduct disorder	0.0189	0.0189	CbGpPWpGaD
Silodosin—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0186	0.0186	CbGpPWpGaD
Silodosin—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0176	0.0176	CbGpPWpGaD
Silodosin—ABCB4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CGA—conduct disorder	0.0138	0.0138	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0136	0.0136	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Other—HTR2A—conduct disorder	0.0133	0.0133	CbGpPWpGaD
Silodosin—UGT2B7—Biological oxidations—COMT—conduct disorder	0.0126	0.0126	CbGpPWpGaD
Silodosin—UGT2B7—Biological oxidations—MAOA—conduct disorder	0.0125	0.0125	CbGpPWpGaD
Silodosin—UGT2B7—Metapathway biotransformation—COMT—conduct disorder	0.0124	0.0124	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0113	0.0113	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—CGA—conduct disorder	0.0103	0.0103	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.01	0.01	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00887	0.00887	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.00858	0.00858	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.00762	0.00762	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0076	0.0076	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—HTR2A—conduct disorder	0.00749	0.00749	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00736	0.00736	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.0067	0.0067	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00654	0.00654	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00631	0.00631	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—COMT—conduct disorder	0.00623	0.00623	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00621	0.00621	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—MAOA—conduct disorder	0.00618	0.00618	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.006	0.006	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.00584	0.00584	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00579	0.00579	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.00579	0.00579	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0056	0.0056	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00556	0.00556	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.00552	0.00552	CbGpPWpGaD
Silodosin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0054	0.0054	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.0053	0.0053	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00496	0.00496	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00494	0.00494	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.00485	0.00485	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0048	0.0048	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.0048	0.0048	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CGA—conduct disorder	0.00476	0.00476	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.0044	0.0044	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00432	0.00432	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.00431	0.00431	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00427	0.00427	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.00427	0.00427	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00412	0.00412	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.00391	0.00391	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	0.00378	0.00378	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00366	0.00366	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00355	0.00355	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	0.00327	0.00327	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.00313	0.00313	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CGA—conduct disorder	0.00313	0.00313	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	0.00297	0.00297	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00289	0.00289	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00287	0.00287	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00285	0.00285	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.00278	0.00278	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—EP300—conduct disorder	0.00267	0.00267	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.0026	0.0026	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—WASF1—conduct disorder	0.00251	0.00251	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.00247	0.00247	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.00241	0.00241	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CGA—conduct disorder	0.00231	0.00231	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	0.00219	0.00219	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—COMT—conduct disorder	0.00215	0.00215	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	0.00213	0.00213	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—MAOA—conduct disorder	0.00213	0.00213	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—WASF1—conduct disorder	0.00208	0.00208	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—WASF1—conduct disorder	0.00185	0.00185	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00185	0.00185	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CGA—conduct disorder	0.00177	0.00177	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	0.00177	0.00177	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DRD4—conduct disorder	0.00175	0.00175	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	0.00157	0.00157	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DRD4—conduct disorder	0.00146	0.00146	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DRD4—conduct disorder	0.00129	0.00129	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	0.00114	0.00114	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CGA—conduct disorder	0.00109	0.00109	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	0.00095	0.00095	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—EP300—conduct disorder	0.000922	0.000922	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	0.000844	0.000844	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—COMT—conduct disorder	0.000801	0.000801	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MAOA—conduct disorder	0.000796	0.000796	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EP300—conduct disorder	0.000607	0.000607	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EP300—conduct disorder	0.000503	0.000503	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—COMT—conduct disorder	0.000494	0.000494	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MAOA—conduct disorder	0.00049	0.00049	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EP300—conduct disorder	0.000447	0.000447	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—EP300—conduct disorder	0.000344	0.000344	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—EP300—conduct disorder	0.000212	0.000212	CbGpPWpGaD
